Furthermore, it modulates the extracellular matrix enzymes MMP-2 and MMP-9 and the urokinase-type plasminogen activator (u-PA) enzymes, all parts of the extracellular matrix remodeling program performed by cancer cells during tumor extravasation and metastasis. The gene discussed is PLAU; the disease is cancer.